Nucleotide-binding sites can enhance N -acylation of nearby protein lysine residues by James, Andrew M. et al.
1
Vol.:(0123456789)
Scientific Reports |        (2020) 10:20254  | https://doi.org/10.1038/s41598-020-77261-1
www.nature.com/scientificreports
Nucleotide‑binding sites can 
enhance N‑acylation of nearby 
protein lysine residues
Andrew M. James1*, Anthony C. Smith1, Shujing Ding1, Jack W. Houghton2, 
Alan J. Robinson1, Robin Antrobus2, Ian M. Fearnley1 & Michael P. Murphy1,3*
Acyl‑CoAs are reactive metabolites that can non‑enzymatically S-acylate and N‑acylate protein 
cysteine and lysine residues, respectively. N-acylation is irreversible and enhanced if a nearby cysteine 
residue undergoes an initial reversible S-acylation, as proximity leads to rapid S → N‑transfer of the 
acyl moiety. We reasoned that protein‑bound acyl‑CoA could also facilitate S → N‑transfer of acyl 
groups to proximal lysine residues. Furthermore, as CoA contains an ADP backbone this may extend 
beyond CoA‑binding sites and include abundant Rossmann‑fold motifs that bind the ADP moiety 
of NADH, NADPH, FADH and ATP. Here, we show that excess nucleotides decrease protein lysine 
N-acetylation in vitro. Furthermore, by generating modelled structures of proteins N‑acetylated in 
mouse liver, we show that proximity to a nucleotide‑binding site increases the risk of N-acetylation 
and identify where nucleotide binding could enhance N-acylation in vivo. Finally, using glutamate 
dehydrogenase as a case study, we observe increased in vitro lysine N-malonylation by malonyl‑
CoA near nucleotide‑binding sites which overlaps with in vivo N-acetylation and N-succinylation. 
Furthermore, excess NADPH, GTP and ADP greatly diminish N-malonylation near their nucleotide‑
binding sites, but not at distant lysine residues. Thus, lysine N-acylation by acyl‑CoAs is enhanced by 
nucleotide‑binding sites and may contribute to higher stoichiometry protein N-acylation in vivo.
Acyl-CoAs are central metabolites in the oxidation of carbohydrate and fat in the mitochondrial matrix, and 
provide the building blocks for biosynthetic reactions in the  cytosol1. However, these metabolites also impact cel-
lular function by N-acylating the ε-amino group of protein lysines. The biological significance of this N-acylation 
is implied by the existence of several sirtuins (Sirt1-7), which use  NAD+ to remove acyl groups from protein 
lysines, and their association with a wide range of degenerative diseases including cancer, ageing and  diabetes2,3. 
As N-acylation displays some site-specificity it was initially considered as a regulatory modification, allowing 
the cell to respond to changes in acyl-CoA, the acyl-CoA/CoA ratio or  NAD+. However, some reassessment was 
required after observing several thousand sites of lysine N-acetylation in vivo4–6, the vast majority of which have 
a very low (~ 0.1%) stoichiometry of  acetylation5,7–9, and that many other N-linked acyl modifications on lysine 
residues are generated in vivo without known transferase  enzymes10–12. This was reinforced by the realisation 
that protein lysines can be non-enzymatically N-acylated by acyl-CoAs7,13,14. Consequently, it was proposed that 
acyl-CoAs represent a ‘carbon stress’, through which chronic exposure to acyl-CoAs causes cumulative cellular 
damage contributing to degenerative diseases and ageing, perhaps explaining the beneficial effects of sirtuins 
and dietary  restriction8,15–17. Supporting this proposal, an analysis of sites of N-acetylation in vivo showed they 
are significantly less conserved than non-acetylated sites within vertebrate  genomes14.
Nevertheless, specific lysine residues or proteins are targeted for N-acylation and this can create the impres-
sion that N-acylation is regulatory. However, while some lysine residues may be intentionally targeted, enhanced 
N-acylation on its own is not necessarily proof of biological regulation. This is because non-enzymatic N-acyla-
tion occurs when the amine group  (pKa ~ 10.5) of a lysine residue deprotonates to become a nucleophile and 
attacks the thioester carbonyl of an acyl-CoA to generate a stable amide-linked protein modification (Fig. 1A)13. 
Enhanced N-acylation of certain lysine residues can occur if their  pKa is lower or if the protein acts as a scaffold to 
increase the local thioester concentration near them (Fig. 1B)7,14,17,18. One example of the later is when S-acylation 
of proximal cysteine residues catalyses N-acylation of nearby  lysines7,9,14,19. This reaction is analogous to ubiquit-
ination where E3 ubiquitin ligases act as adaptors to localise S-ubiquitinated E2 proteins close to proteins destined 
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Figure 1.  Nucleotide-binding sites could facilitate N-acylation of proximal lysine residues by acyl-CoAs. (A) 
The thioester of an acyl-CoA can directly and irreversibly N-acylate a lysine residue, but the high  pKa of a 
primary amine (~ 10.5) means this reaction is relatively  slow13. (B) In contrast, the reaction of an acyl-CoA with 
a protein cysteine thiolate  (pKa =  ~ 8.5) is ~ 100-fold faster, but reversible. However, once the thioester localises 
to the protein surface it can react quickly and irreversibly with nearby lysine  amines7,9,14,17. (C) Many common 
metabolic cofactors share an ADP-moiety with CoA. (D) ADP-binding sites could also localise acyl-CoAs to the 
protein surface causing rapid and irreversible N-acylation of nearby primary amines. Pant pantetheine.
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to be N-ubiquitinated. In both cases this S → S → N-transfer strategy is effective because proximity enhances the 
second rate-limiting step. Interestingly, CoA shares an ADP backbone with many nucleotide cofactors such as 
ATP, NADH, NADPH and FADH (Fig. 1C) and this common backbone is recognised and bound by the ubiqui-
tous Rossmann fold  motif20. Thus, we reasoned that proteins with nucleotide binding sites could act as scaffolds 
to enhance N-acylation of nearby lysine residues by acyl-CoAs (Fig. 1D).
Here we show that lysine N-acylation by acyl-CoAs is enhanced by interactions between acyl-CoAs and 
nucleotide-binding sites on the protein surface, and that this mechanism may contribute to elevated protein 
N-acylation in vivo.
Results
Excess adenine nucleotides decrease lysine N‑acetylation of mitochondrial proteins by 
acetyl‑CoA in vitro. Previously we had observed a high apparent KM of ~ 5 mM for N-acetylation of mito-
chondrial membrane proteins by acetyl-CoA in vitro and that this N-acetylation was sensitive to  CoA7. This 
could occur if acetyl-CoA binds weakly to the surface of proteins before transferring its acetyl moiety. We rea-
soned that such a CoA-protein association would enhance N-acetylation of nearby lysine residues (Fig. 1D) via 
a mechanism that could be antagonised by co-incubation with structural mimetics of CoA (Fig. 2A). To assess 
this possibility, fragments of bovine heart mitochondrial membranes were incubated with 2 mM acetyl-CoA and 
the effect of 10 mM CoA on the degree of protein lysine N-acetylation was quantified (Fig. 2B). This showed that 
51 ± 3% of N-acetylation by acetyl-CoA was prevented by a fivefold excess of CoA (Fig. 2C). A similar magnitude 
effect was observed with 10 mM dephosphoCoA (Fig. 2B). As these effects could be explained thermodynami-
cally by the effect of the free thiols of CoA or dephosphoCoA on the acetylation potential of acetyl-CoA we next 
assessed the effect of the component parts of acetyl-CoA (10 mM) on lysine N-acetylation. Adding ADP pre-
vented 36 ± 6% of the acetylation, whereas adding AMP was less effective at suppressing acetylation (Fig. 2B). 
Adding pantetheine, the non-nucleotide thiol-containing component of CoA, was also less effective (Fig. 2B). 
Thus, association of the nucleotide diphosphate moiety of acetyl-CoA with protein appears to enhance lysine 
N-acetylation.
This mechanism of N-acylation may not be limited to proteins where CoA is a high-affinity substrate. CoA, 
NADPH, NADH, ATP and FADH all share an ADP backbone (Fig. 1C), and binding sites for these cofactors 
are all based around the Rossmann-fold structural motif that recognises  ADP21. Consequently, any protein con-
taining an ADP-binding Rossmann fold could potentially bind acyl-CoAs, leading to enhanced N-acylation of 
nearby lysine residues through this  association22. When fragments of bovine heart mitochondrial membranes 
were incubated with 2 mM acetyl-CoA and 10 mM of various nucleotides, the metabolic cofactors ATP, NADPH 
and FAD, all significantly decreased protein lysine N-acetylation (Fig. 2C).
This result suggests the nucleotide moiety of acetyl-CoA can cause its association with the surface of proteins 
that bind common nucleotide-based cofactors, leading to enhanced N-acetylation of nearby lysine residues.
A 3D structural library of mouse liver proteins with bound nucleotides and N‑acetylated 
lysines. Although the above data were consistent with our initial hypothesis, the presence of other com-
peting non-enzymatic mechanisms for N-acylation (Fig. 1A,B) made definitive analysis difficult. Therefore, to 
explore whether nucleotide-binding sites can enhance N-acylation and identify candidate proteins for further 
detailed investigation, we generated a dataset of modelled N-acetylated protein structures with bound ADP-
based cofactors and related artificial structural analogues (Supplementary Table S1). We began with an in vivo 
dataset of 4319 N-acetylated lysine residues in mouse  liver5,6. From this dataset we took the protein sequences 
of the N-acetylated peptides and, using the most homologous existing protein structure as a template, we built 
single-subunit models of the mouse proteins with their bound nucleotide  analogues14,23. Then we calculated the 
distances from the amine nitrogen atom (NZ) of each protein lysine to the bound nucleotide ligand atom equiva-
lent to the thiol sulphur atom (S1P), the β-phosphate (P2A), α-phosphate (P1A) and the ribose 5′ carbon (C5B) 
of acetyl-CoA (Fig. 2D). Analysis of the small subset of proteins where the bound analogue contains an atom 
equivalent to the S1P of CoA indicated that lysine residues with higher N-acetylation stoichiometry (> 0.4%, 
n = 9) were significantly more likely to be near this S1P atom of the bound CoA analogue than less N-acetylated 
residues (< 0.4%, n = 48; Fig. 2E and Supplementary Table S1).
However, assessing proteins that bind cofactors such as ADP, NAD(H) and NADP(H) is more complicated 
than for those binding CoA as the pantetheine group of an acyl-CoA is flexible and probably unrecognised by 
the protein. Consequently, its thioester may be tethered 15 Å away from the pivot point of the β-phosphate of 
the bound ADP moiety (Fig. 2D). Furthermore, as the reactive distance previously observed for the transfer 
of an acyl moiety from a surface cysteine residue to a protein lysine is ~ 10 Å14, lysine residues that can react 
with the thioester may be up to ~ 10 Å further away. This creates uncertainty about the location of the thioester 
and the lysine residues it can react with. Even so, using the complete dataset indicated that lysine residues with 
higher N-acetylation stoichiometry (> 0.4%, n = 46) were also significantly more likely to be near the ribose 5′ 
carbon atom of the bound nucleotide analogue than less N-acetylated residues (< 0.4%, n = 717; Fig. 2F and 
Supplementary Table S1).
Lysine N‑malonylation of glutamate dehydrogenase is decreased by nucleotides. Although 
the single-subunit data in Supplementary Table S1 supports the hypothesis that nucleotide-binding sites on the 
surface of proteins enhance N-acylation of nearby lysine residues, it cannot fully capture the nucleotide-protein 
interaction. This is because native proteins are frequently multimeric, some nucleotide-binding sites may be 
unoccupied in the chosen structure, protein surface features can sterically prevent an acyl-transfer reaction 
at distances beyond ~ 15  Å14, and other mechanisms, such as exposed cysteine residues, can catalyse lysine 
4
Vol:.(1234567890)
























































































































































































































































































































Scientific Reports |        (2020) 10:20254  | https://doi.org/10.1038/s41598-020-77261-1
www.nature.com/scientificreports/
N-acylation on the surface of proteins (Fig. 1B)14. Therefore, it was necessary to confirm whether this potential 
mechanism of N-acetylation occurred at particular sites on an individual candidate protein.
Glutamate dehydrogenase (GDH) is an excellent candidate because it contains numerous N-acetylation sites 
and no surface cysteine residues where > 2 Å2 of the thiol sulphur atom is solvent exposed (Supplementary 
Table S1). Furthermore, purified bovine GDH was commercially obtainable and molecular structures of hexam-
eric bovine GDH with NAD(P)H, GTP and ADP bound were available facilitating distance calculations for each 
of its three nucleotide binding sites (Fig. 3A)24,25. Trial incubations indicated that purified bovine liver GDH could 
be N-acetylated, N-succinylated and N-malonylated in vitro by their respective acyl-CoAs (Fig. 3B). However, 
purified bovine liver GDH was already extensively N-acetylated, resulting in an unsuitably high background for 
in vitro measurements (Fig. 3B). While succinyl-CoA caused rapid N-succinylation, this may be less dependent 
on nucleotide-binding sites as its reaction mechanism can proceed via succinic  anhydride26. In contrast, malonyl-
CoA is too small to form an anhydride  intermediate26 and purified mitochondrial GDH was not extensively 
N-malonylated (Fig. 3B). Consequently, malonyl-CoA was chosen to explore whether N-acylation of GDH is 
enhanced by its nucleotide-binding sites.
In vitro, malonyl-CoA caused N-malonylation of GDH in a time and concentration dependent manner 
(Fig. 3B). As phosphate (50 mM) may impact on nucleotides binding to GDH this was omitted from these and 
future  experiments27. N-malonylation of GDH could be inhibited by a five-fold excess of CoA, dephosphoCoA, 
ADP or AMP, but not of phosphate (Fig. 3C). Of these ADP was the most effective, preventing 66 ± 2% of the 
N-malonylation. Consistent with the two phosphates of ADP being important for binding to a Rossmann  fold21, 
AMP was significantly less effective than ADP, preventing only 41 ± 4% of N-malonylation. Hexameric molecular 
structures for bovine GDH (PDB IDs: 6DHD, 6DHQ and 6DHK) show a catalytic binding site for NAD(P)H and 
separate allosteric binding sites for GTP and NADH/ADP (Fig. 3A)24,25. GTP, GDP, ATP and ADP all  prevented 
~ 60% of the malonylation (Fig. 3D). Interestingly,  NAD+, NADH,  NADP+ and NADPH displayed different 
propensities to prevent N-malonylation with NADPH (80 ± 3%) more inhibitory than NADH (55 ± 4%),  NADP+ 
(38 ± 3%), or  NAD+ (18 ± 8%). This likely reflects cumulative differences in KD at the three nucleotide-binding 
sites for each of these competing nucleotides.
When analysed by LC–MS/MS, purified bovine liver GDH contained several N-acetylated and N-succinylated 
peptides (Fig. 3E), consistent with its in vivo exposure to acetyl-CoA and succinyl-CoA in the mitochondrial 
matrix. In contrast, there was little evidence of N-malonylation of purified GDH, consistent with the predomi-
nant cytosolic location of malonyl-CoA (Fig. 3E). When purified GDH was exposed to 2 mM malonyl-CoA for 
6 h at 37 °C there was a 138 ± 30-fold increase in total ion current (TICs) from the nine N-malonylated peptides 
that could be identified with no increase in N-acetylated or N-succinylated peptides (Fig. 3E). Consistent with 
quantification by western blot (Fig. 2B,C) addition of 10 mM NADPH, GTP or ADP prevented much of the 
N-malonylation by 2 mM malonyl-CoA (Fig. 3E). Thus, GDH can be N-acylated by acyl-CoAs in a manner 
consistent with their prebinding to cofactor binding-sites.
Lysine N‑malonylation of GDH is increased near nucleotide‑binding sites. One prediction of our 
model is that N-acylation of lysine residues will be greater near the nucleotide binding sites of GDH. The major-
ity (88%) of the TICs from the nine N-malonylated GDH peptides arise from peptides containing K503 (75 ± 2%; 
4.3 Å) and K183 (13 ± 1%; 8.9 Å), the two lysines closest to the β-phosphate of the nucleotide bound to each 
binding site (Fig. 4A). K503 also accounts for 62 ± 4% and 59 ± 3% of the TICs from pre-existing N-acetylation 
and N-succinylation on purified GDH. This suggests that the association of acyl-CoAs with nucleotide-binding 
sites is not a feature of specific acyl-CoAs and is a significant mechanism by which GDH becomes N-acylated 
in vivo (Supplementary Table S2).
While TICs can only give an approximation of the relative stoichiometry when comparing different peptides, 
N-acetylation stoichiometry for particular lysine residues was previously quantified for mouse liver proteins 
in vivo, and this showed that K503 was also the most N-acetylated lysine residue within GDH (1.63%, Sup-
plementary Table S2)5. Furthermore, the five most N-acetylated lysine residues of GDH in mouse liver in vivo5 
cluster near the overlapping allosteric binding sites for GTP and ADP/NADH (Fig. 4B). Interestingly, despite 
strong N-malonylation of K183 near the active site in vitro, this was not observed for either N-acetylation or 
Figure 2.  N-acetylation of protein by acetyl-CoA is facilitated by nucleotide-binding sites. (A) Acetyl-CoA 
associates with nucleotide binding sites leading to faster protein N-acetylation and this is slowed by excess 
adenine nucleotides competing for these sites. (B,C) Excess adenine nucleotides decrease protein N-acetylation. 
Bovine mitochondrial membrane proteins were incubated with 2 mM acetyl-CoA for 6 h at 37 °C with or 
without 10 mM excess adenine nucleotides. N-acetylated proteins were separated by SDS-PAGE and quantified 
by western blot using an anti-acetyllysine antibody. After subtraction of the no acetyl-CoA signal from all lanes, 
data was expressed relative to the signal from proteins incubated with 2 mM acetyl-CoA alone. Data were 
the mean ± SEM (n = 3–9). Significance was determined using a paired two-tailed t-test relative to the 2 mM 
acetyl-CoA alone signal from the same western blot; *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001. (D) 
Atoms of acetyl-CoA used for modelling in Supplementary Table S1. The distance from the pivot β-phosphate 
(2PA) of the bound ADP moiety recognized by a Rossmann fold to the tethered reactive thioester carbonyl 
is shown. (E,F) Increased lysine N-acetylation occurred near nucleotide binding sites in mouse liver in vivo. 
N-acetylated lysine residues were grouped by their stoichiometry of N-acetylation5 and ranked by the distance 
from NZ amine of N-acetylated lysine residues to either the thioester sulphur (S1P; E) or ribose 5′ carbon (5CB; 
F) atoms of protein-bound nucleotides (Supplementary Table S1). Data are presented as Kaplan–Meier plots of 
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N-succinylation with purified GDH or for N-acetylation in mouse liver in vivo (Supplementary Table S2)5. This 
likely reflects the presence of competing nucleotides in vivo and binding site-specific differences in KD between 
acyl-CoAs and these competing nucleotides.
Nucleotides decrease malonylation of GDH near their nucleotide‑binding sites. There are three 
distinct sites on GDH where NAD(P)H, GTP and ADP  bind25, and adding these nucleotides prevented much of 
the N-malonylation by malonyl-CoA (Fig. 3E). A second prediction of our hypothesis is adding these nucleo-
tides will most effectively inhibit N-acylation near their nucleotide-binding sites on GDH. For each inhibitory 
nucleotide used its β-phosphate position was identified in the appropriate GDH structure (PDB IDs: 6DHD, 
6DHQ and 6DHK) and the distance to each lysine residue was calculated (Fig. 5A and Supplementary Table S2). 
Grouping of lysine residues into the three near the active site (K183, K191 and K352), the three closest to the 
appropriate allosteric site (K503, K545 and either K84 or K527) and the three farthest from either site (K390, 
K480 and either K84 or K527), showed a significant correlation between proximity of a lysine to a nucleo-
tide binding site and inhibition of N-malonylation by a fivefold excess of a nucleotide with affinity for that site 
(Fig. 5A,B). Although NADPH is shown binding to the active site of GDH (PDB ID: 6DHQ), it is also likely to 
bind to the allosteric site containing NADH (Fig. 3D; PDB ID: 6DHD).
Despite the strong correlation in Fig. 5B this relationship is expected to breakdown beyond ~ 25 Å—the 
combined distance of the ~ 15 Å flexible pantetheine linker of an acyl-CoA when extended (Fig. 2A) and the 
~ 10 Å proximity required for the reaction of a thioester with an  amine14. When distance is graphed relative to 
the degree of inhibition of N-malonylation at that lysine residue, there is a striking sigmoidal relationship for 
the nucleotides, GTP and ADP, that have only a single binding site (Fig. 5C). For lysine residues < 15 Å from the 
β-phosphate, the inhibition plateaus at ~ 95%, whereas those further away than 25 Å experience ~ 30% inhibition. 
Inhibition transitions between these distances, with the distance  (IDist50) at which a lysine residue experiences 
half of this inhibition being 22.3 Å (Fig. 5C). In most cases these distances are too far for nucleotides such as GTP 
or ADP to sterically hinder N-malonylation simply by preventing access of malonyl-CoA to the lysine residue.
The probable binding of NADPH to two sites complicated detailed analysis as eight of the nine N-malonylated 
lysine residues were within 25 Å of the β-phosphate of bound NAD(P)H and N-malonylation was inhibited > 50% 
by NADPH at each of these eight lysine residues (Fig. 5A). However, NADPH inhibited N-malonylation of 
residues K183, K191 and K352 near the active site (10.9 Å) more effectively than GTP (24.9 Å) or ADP (29.9 Å) 
suggesting malonyl-CoA binds to the active site in vitro and N-malonylates the proximal lysine residues (Fig. 5D).
Residues that are neither N‑malonylated nor inhibited by excess nucleotides are distant from 
nucleotide‑binding sites. A final prediction of our hypothesis is that lysine residues far from the nucleo-
tide-binding sites of GDH will have weak or undetectable N-malonylation and that if N-malonylation is observed 
it will be insensitive to inhibition by nucleotides. In addition to the nine malonylated peptides identified here 
(Fig. 5A), bovine GDH contained a further 22 surface lysine residues that were not identified as N-malonylated 
by LC–MS/MS and where > 2 Å2 of their amine NZ atom was solvent exposed (Supplementary Table S2). While 
this lack of identification could arise because peptides are too short or too long for LC–MS/MS, it could also 
occur if the degree of N-malonylation was low. As peptides identified as N-malonylated here ranged from 9 to 
20 amino acids in length detection of a further seven of the 22 non-malonylated surface lysine residues might be 
expected if they were N-malonylated (Supplementary Table S2). Furthermore, detectable N-malonylation that 
is weakly inhibited by excess nucleotides could also occur at lysine residues distant from nucleotide-binding 
sites. Thus, lysine residues that were N-malonylated with weak inhibition (< 60%) by all of the excess nucleotides 
(K390 and K480) and peptides of detectable length but not detected as N-malonylated (K68, K110, K162, K200, 
K212, K363 and K399) were grouped and compared to lysine residues that were N-malonylated with strong 
inhibition (> 60%) by an excess of at least one nucleotide (K84, K183, K191, K352, K503, K527 and K545). This 
Figure 3.  N-acetylation of GDH by acyl-CoA is facilitated by nucleotide-binding sites. (A) Hexameric GDH 
(PDB ID: 6DHD) with two bound NADH (pink, active site; green, allosteric site) and one GTP (yellow). A 
20 Å sphere centred on the β-phosphate of each bound nucleotide is shown for scale to indicate the reach of 
the thioester of a bound acyl-CoA. Lysine amines identified as N-acetylated in mouse  liver5 are depicted as red 
spheres whereas others are blue. (B) N-acylation of GDH increases with time and acyl-CoA concentration. 
Purified bovine GDH was exposed to 0–2 mM acetyl-CoA, malonyl-CoA or succinyl-CoA for 0–6 h at 37 °C 
before resolution on separate SDS-PAGE gels and detection with antibodies specific for anti-acetyllysine, 
anti-malonyllysine or anti-succinyllysine7, respectively. Full-length western blots are in Supplementary Fig. S1. 
(C,D) N-malonylation can be blocked by excess purine nucleotides. Purified bovine GDH was exposed to 
2 mM malonyl-CoA and either 10 mM CoA, dephosphoCoA, ATP, ADP, AMP, GTP, GDP, NADH,  NAD+, 
NADPH,  NADP+ or  Pi for 6 h at 37 °C before resolution on separate SDS-PAGE gels and detection with an 
anti-malonyllysine antibody. Full-length western blots are in Supplementary Fig. S1. Data are expressed relative 
to GDH incubated with 2 mM malonyl-CoA alone from the same gel. Data are the mean ± SEM (n = 3–6). 
Significance was determined using a paired two-tailed t-test relative to 2 mM malonyl-CoA alone (*) or 2 mM 
malonyl-CoA with 10 mM ADP (§) signal from the same western blot; ** or §§, p < 0.01; ***, p < 0.001; ****, 
p < 0.0001. (E) N-malonylation can be blocked by excess purine nucleotide cofactors. Purified bovine GDH was 
exposed to 2 mM malonyl-CoA and 10 mM ADP, GTP, or NADPH for 6 h at 37 °C before trypsinisation and 
LC–MS/MS analysis. The total ion currents (TICs) for 9 N-acylated peptides were combined and expressed 
relative to a control peptide (DDGSWEVIEGR). Data are the mean ± SEM (n = 4). Significance was determined 
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analysis showed that lysine residues having undetectable or weak N-malonylation that was insensitive to inhibi-
tion by excess nucleotides were further from nucleotide-binding sites (Fig. 5E; p < 0.0001).
Discussion
Irreversible protein lysine N-acylation by acyl-CoAs can occur directly but  slowly13. We have shown previously 
that reversible initial S-acylation of a cysteine residue can lead to much greater N-acetylation of a nearby lysine 
 residue7,14. This is because the protein acts as a scaffold to increase the local thioester concentration near the 
amine of proximal lysine  residues17. Here we show that N-acylation of both mitochondrial protein and purified 
GDH is diminished by an excess of purine nucleotide cofactors. This suggests that binding sites for nucleotide 
cofactors can bind acyl-CoAs and thereby facilitate N-acylation of nearby lysine residues. A detailed in vitro 
case study of GDH showed N-malonylation by malonyl-CoA was most detectable at K503, which is near two 
overlapping allosteric sites that bind GTP or ADP/NAD(P)H, and at K183, which is near the active site (Fig. 3A) 
that binds NAD(P)H. Addition of an excess of NADPH led to the loss of ~ 95% of the N-malonylation at both 
sites, whereas excess of GTP or ADP led to the loss of up to 95% of the N-malonylation at K503. In contrast, 
N-malonylation of residues distant (> ~ 25 Å) from these nucleotide-binding sites was either uninhibitable by 
excess nucleotides or undetectable by LC–MS/MS (Fig. 5E).
These in vitro observations are only partially replicated in vivo, as although K503 is also the main site of 
N-acetylation in mouse liver and on purified GDH, N-acetylation of active site K183 is not observed in vivo5. The 
KM values of bovine liver GDH for NAD(P)H and NAD(P) are ~ 0.02 and ~ 0.2 mM,  respectively28,29, indicating 
high occupancy of the active site in vivo. In contrast, to allow responsiveness to metabolic changes, regulatory 
allosteric sites would be expected to have lower occupancy at physiological cofactor concentrations in vivo, 
thereby allowing better access to acyl-CoAs. Thus, the relative lack of active-site K183 N-acylation in vivo prob-
ably reflects the presence of competing nucleotides perhaps combined with differences in occupancy between 
the active and allosteric sites.
The relevance of this mechanism for proteins other than GDH will have to be addressed on a case-by-case 
basis. For example, it has been proposed that N-malonylation of glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) occurs because malonyl-CoA can occupy its binding site for NAD(H)30,31. Five of the six most N-acety-
lated lysine residues in mouse liver lie near this NAD(H) binding site (Table S1)5. Interestingly, the dataset we used 
to generate Table S1 had specifically excluded histones as this protein family contains many common  peptides5. 
Histones interact with nucleotides using positively charged lysine and arginine residues and many different 
N-acyl lysine modifications have been identified on histones for which there are no known N-acyltransferases. 
This group includes such esoteric histone modifications as N-crotonylation32, N-2-hydroxyisobutyrylation33, 
K503





































Figure 4.  Lysine N-acylation of GDH is increased near its nucleotide-binding sites both in vitro and in vivo. 
(A) The N-malonylation signal is highest for lysine residues near nucleotide binding sites. GDH was exposed 
to 2 mM malonyl-CoA for 6 h at 37 °C before trypsinisation and LC–MS/MS. Total ion currents (TICs) for 
individual N-malonylated peptides were expressed relative to a control peptide (DDGSWEVIEGR). Relative 
TICs are not quantitative as MS response differs between peptides. Distances are from the lysine amine to 
the β-phosphate of the nearest nucleotide in Supplementary Table S2. Data are the mean ± SEM (n = 4). (B) 
Location and stoichiometry of in vivo lysine N-acetylation sites on hexameric GDH (PDB ID: 6DHD). A sphere 
proportional to N-acetylation stoichiometry (1.55 Å/0.2% acetylation stoichiometry) in mouse liver is centred 
on each lysine amine (NZ). N-acetylation stoichiometry is from Weinert et al.5. A threshold stoichiometry of 
> 0.2% is needed to exceed the 1.55 Å van der Vaals radius of the nitrogen atom. Lysine amines not detected as 
N-acetylated or with a stoichiometry of < 0.2% in mouse liver are coloured blue (Supplementary Table S2)5.
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N-lactylation34, N-propionylation and N-butyrylation35. Although each of these may represent a transferase-
dependent regulatory signal, histones have evolved to interact with nucleotides and consequently may find it 
difficult to avoid interacting with acyl-CoAs and thereby becoming acylated too.
Finally, we show here that proteins with nucleotide-binding sites for common metabolic cofactors can poten-
tially act as scaffolds for N-acylation. This is similar to a previously described mechanism where proximal cysteine 
residues catalyse N-acylation7,9,14. Both mechanisms work by enhancing the local thioester concentration, thereby 
leading to the targeting of certain lysine  residues17. While this specificity could lead to regulation, N-acetylation 
stoichiometry appears to be, in most cases at least, too low for simple loss of function  effects5,9. Furthermore, the 
vast majority of N-acylation sites catalysed by cysteine residues appear to lack a biological purpose as they were 
significantly less conserved within the genomes of  vertebrates14. The degree to which the nucleotide-binding 
site driven acylation described here leads to functional regulation rather than just indicating a chemical side 
reaction will need further investigation.
Materials and methods
Materials. Nucleotide cofactor stocks (40 mM) were prepared in 200 mM HEPES and neutralised (pH ~ 7.8; 
NaOH) where necessary. The pH was checked with pH strips with the exception of FAD because its colour inter-
fered and neutrality had to be assumed. As small differences in pH could be critical, further additional buffering 
capacity was included in the reaction. Bovine hearts were from cattle of mixed gender and aged 18–22 months 
(C Humphreys & Sons Abattoir, Chelmsford, UK). Bovine heart mitochondrial membrane fragments were pre-
pared as described previously and stored at − 80  °C until  used36. Lyophilised glutamate dehydrogenase from 
bovine liver (Type III, Sigma) was reconstituted in 100 mM HEPES (pH 7.8; NaOH). Rabbit anti-acetyllysine 
(9441) antibody was from Cell Signaling Technology (Danvers, USA). Rabbit anti-succinyllysine (PTM-401) 
and anti-malonyllysine (PTM-901) primary antibodies were from PTM Biolabs (Chicago, USA). Mouse anti-
NDUFB8 (ab110242) primary antibody was from Abcam (Cambridge, UK). Anti-mouse and anti-rabbit fluo-
rescent secondary antibodies were from LI-COR Biosciences (Lincoln, USA). All other enzymes and chemicals 
were from Sigma.
Protein incubations. Bovine heart mitochondrial membrane fragments (100 µg protein) were incubated in 
20 µL of  NaPi/HEPES buffer (50 mM  NaH2PO4, 100 mM HEPES [pH 7.8, NaOH]). GDH (5 µg) was incubated 
in 20 µL of HEPES buffer (100 mM HEPES [pH 7.8, NaOH]). Incubations were supplemented with 10 mM 
CoA, dephospho-CoA, pantetheine, ATP, ADP, AMP, GTP, GDP, NADH, NADPH,  NAD+,  NADP+, FAD or  Pi 
as indicated. The reaction was started with 2 mM of either acetyl-CoA, succinyl-CoA or malonyl-CoA and then 
incubated for 6 h at 37 °C.
SDS‑PAGE. DTT (5 µL, 1 M) was added to each 20 µL sample of GDH to remove cysteine-bound acetyl 
groups before mixing 1:1 with SDS-PAGE loading buffer. Samples were separated on a 12% SDS-PAGE gel and 
samples with no acyl-CoA, 2 mM acyl-CoA, and 2 mM acyl-CoA with 10 mM CoA, were included on all gels. 
Proteins were transferred from gels to PVDF and incubated overnight at 4 °C with Odyssey Blocking Buffer. The 
PVDF membrane was probed with 1/2000 dilution of rabbit anti-acetyllysine, rabbit anti-succinyllysine or rabbit 
anti-malonyllysine and 1/5000 mouse anti-NDUFB8 in Odyssey Blocking Buffer for 1 h at 25 °C. It was washed 
three times with PBS/0.1% Tween-20 (PBST) before incubation for 1 h at 25 °C with 1/10,000 anti-mouse and 
anti-rabbit fluorescent secondary antibodies in Odyssey Blocking Buffer. After washing three times with PBST 
and twice PBS, fluorescence intensity was measured at 680 nm and 800 nm using a LI-COR Odyssey CLx near-
infrared imaging system and Image Studio v4.0. Background intensity from a sample with no acyl-CoA was sub-
tracted from the intensity of all acyl-CoA treated lanes and then the data were expressed relative to the intensity 
of a lane treated with 2 mM acyl-CoA alone.
Mass spectrometry of GDH. Each 20 µL sample of GDH was incubated with excess DTT (2.5 µL, 50 mM) 
and SDS (2.5 µL, 10%) for 15 min at 37 °C. This was followed by incubation for 30 min at 37 °C with a greater 
excess of iodoacetamide (5 µL, 200 mM). After adding DTT (7.5 µL, 1 M), samples were mixed 1:1 with SDS-
PAGE loading buffer. Samples were resolved on a 12% SDS-PAGE gel, stained with colloidal Coomassie and the 
GDH band excised. Proteins contained in the gel bands were cleaved in-gel with trypsin (12.5 mg/µL, overnight 
at 37  °C). The LC–MS/MS analysis of tryptic peptides was carried out using a Q-Exactive+ mass spectrom-
eter (Thermo Scientific) after chromatography on a nanoscale reverse-phase PepMap column (50  µm inner 
diameter, 150 mm length) with a gradient of 0–40% buffer B (95% acetonitrile, 0.1% formic acid) in buffer A 
(5% acetonitrile, 0.1% formic acid) over 84 min at 300 nL/min. Four replicate samples were processed for each 
experimental condition. Peptides were identified using Proteome Discoverer (Thermo Scientific) and the Mascot 
protein identification program (Matrix Science). All experiments used the mammalian protein subset of the 
UniProt database (2015_7). Searches were performed using a 5 ppm and 0.01 Da mass tolerance for precursor 
and fragment ions respectively, while requiring each peptide’s amino/carboxy (N/C) terminus to have trypsin 
protease specificity and allowing up to two missed tryptic cleavages. N-malonylation (+ 87.042  Da), N-acet-
ylation (+ 42.037 Da) and N-succinylation (+ 100.073 Da) of lysine residues as well as methionine oxidation 
(+ 15.995 Da) were set as variable modifications and carbamidomethyl (+ 57.051 Da) was used as a fixed modi-
fication for cysteines. As sequence information from MS2 data was not present for all peptides in all replicate 
samples, the raw files of samples lacking appropriate MS2 data were manually analysed and peaks were identi-
fied on the basis of their m/z values and observed retention time from other replicates. To control for loading 
differences between runs, ion counts of N-acylated peptides were normalised to ion counts of a control peptide 
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Lys Active Site Closest Allosteric Allosteric 
Residue NADPH (Å) NADH (Å) Site GTP (Å) Site ADP (Å) NADPH GTP ADP
K84 32.4 18.2 21.3 22.8 49.3% 54.5% 38.1%
K183 9.7 8.9 24.5 24.4 4.6% 55.6% 67.1%
K191 12.1 13.2 27.6 33.5 22.8% 74.1% 65.9%
K352 10.6 10.6 22.4 31.8 15.1% 29.8% 54.3%
K390 28.9 27.8 44.2 40.3 132.6% 112.9% 70.0%
K480 54.0 49.8 37.5 38.4 45.8% 60.7% 83.3%
K503 24.3 16.6 5.1 14.1 11.6% 4.6% 2.4%
K527 35.8 21.8 23.4 18.4 41.5% 73.8% 26.0%
K545 25.2 10.6 20.9 8.2 25.8% 16.8% 7.5%
Malonylation
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DDGSWEVIEGR. This was the only peptide of equivalent size (9–20 residues) with flanking arginine residues 
and no oxidisable methionines.
Structural models of CoA analogue‑bound mouse proteins. A list of analogues of CoA, ADP,  NAD+ 
and FAD that are found as ligands in molecular structures (Table S1A) was created using the ‘similar’ function 
of the ligand database of the Protein Data Bank (PDB)37. A list of N-acetylated proteins from mouse liver tis-
sue was taken from published  data5. If an analogue-bound structural file for an N-acetylated protein could be 
identified, the corresponding mouse protein sequences were taken from UniProt and individually aligned using 
 MODELLER38 with those sequences in a non-redundant PDB sequence database clustered at 95%. The best 
match having a minimum sequence identity of 50% across their entire length of the query sequence and contain-
ing the analogue was then used as a structural template. Then the query sequence was structurally aligned with 
the template and this was used to create five single-subunit predicted structures, with the one with the lowest 
DOPE score retained for analysis. After alignment, the nucleotide analogue was copied to the modelled mouse 
structure. Atoms corresponding to the thiol sulphur atom (S1P), the β-phosphate (P2A), α-phosphate (P1A) and 
the ribose 5′ carbon (C5B) of acetyl-CoA were identified for each nucleotide analogue (Table S1B). Distances 
between modelled mouse lysine amine atoms (NZ) and bound nucleotide analogue atoms of interest were cal-
culated using trigonometry from the 3D coordinates in the generated PDB files. For each structure the solvent 
accessible area in Å2 of every atom was calculated using areaimol from the CCP4 software  suite39.
For hexameric bovine GDH, distances between lysine amine atoms (NZ) and bound nucleotide analogue 
atoms of interest were calculated using trigonometry from the 3D coordinates in published PDB files (6DHD, 
6DHQ and 6DHK)25. Structures were visualized with the PyMOL Molecular Graphics System (version 1.8.4 
Schrödinger, LLC).
Statistics and data processing. Statistical significance was calculated using Prism version 7 for Mac 
(GraphPad). Significance for cumulative frequency was determined with a Kaplan–Meier plot followed by a 
Gehan-Breslow-Wilcoxon test. Otherwise statistical significance was determined using a two-tailed Student’s 
t-test, one-way ANOVA followed by Sidak’s multiple comparison test or linear regression as indicated.
Data availability
All data generated or analysed during this study are included in this published article (and its Supplementary 
Information Tables S1 and S2). Modelled structures used in the current study are available from the correspond-
ing author on reasonable request.
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